Efficacy and safety of "sandwich" therapy (initial Interferon induction with end-treatment Interferon boost) with Rebetron in the treatment of naive patients with chronic hepatitis C.

被引:0
|
作者
Bassan, I [1 ]
Bloom, ML [1 ]
Phillips, RS [1 ]
Muirhead, S [1 ]
Garrison, S [1 ]
机构
[1] Pharma Res Grp Inc, Miami Beach, FL USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1699
引用
收藏
页码:597A / 597A
页数:1
相关论文
共 50 条
  • [31] Safety and efficacy of viramidine in combination with pegylated interferon alfa-2a for treatment of hepatitis C in therapy-naive patients
    Gish, R
    Arora, S
    Nelson, D
    Fernandez, H
    Lamon, K
    JOURNAL OF HEPATOLOGY, 2004, 40 : 141 - 142
  • [32] Interferon/ribavirin treatment in interferon non-responders with chronic hepatitis C.
    Teuber, G
    Berg, T
    Leidig, L
    Hoffmann, RM
    Lafrenz, M
    Spengier, U
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [33] Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C
    Huang, Chung-Feng
    Yang, Jeng-Fu
    Dai, Chia-Yen
    Huang, Jee-Fu
    Hou, Nai-Jen
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05): : 751 - 759
  • [34] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
    Vlodov, J
    Charania, M
    Jose, RM
    Iswara, K
    Lapin, S
    Terebelo, S
    Bernstein, M
    Tenner, S
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [35] Efficacy and safety of an initial daily dosing regimen of interferon-alpha-2A in treatment-naive patients with chronic hepatitis C and HCV genotype 1
    Desch, S
    Vaeth, T
    Tamba, M
    Klinker, H
    Langmann, P
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2001, 6 (06) : 242 - 246
  • [36] Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment
    Neukam, K.
    Mira, J. A.
    Gilabert, I.
    Claro, E.
    Vazquez, M. J.
    Cifuentes, C.
    Garcia-Rey, S.
    Merchante, N.
    Almeida, C.
    Macias, J.
    Pineda, J. A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (06) : 1225 - 1232
  • [37] Continuous combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Cantu, NS
    Kadakia, SC
    HEPATOLOGY, 2001, 34 (04) : 585A - 585A
  • [38] Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment
    K. Neukam
    J. A. Mira
    I. Gilabert
    E. Claro
    M. J. Vázquez
    C. Cifuentes
    S. García-Rey
    N. Merchante
    C. Almeida
    J. Macías
    J. A. Pineda
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1225 - 1232
  • [39] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [40] Apoptosis induction in PBMCs during interferon therapy for chronic hepatitis C.
    Wurzer, G
    Kobryn, T
    Ulbrich, G
    Watkins-Riedel, T
    Jessner, W
    Gangl, A
    Ferenci, P
    Peck-Radosavljevic, M
    HEPATOLOGY, 2001, 34 (04) : 419A - 419A